DekaBank Deutsche Girozentrale’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $879K | Hold |
15,800
| – | – | ﹤0.01% | 889 |
|
|
2025
Q1 | $771K | Hold |
15,800
| – | – | ﹤0.01% | 889 |
|
|
2024
Q4 | $610K | Hold |
15,800
| – | – | ﹤0.01% | 962 |
|
|
2024
Q3 | $709K | Hold |
15,800
| – | – | ﹤0.01% | 944 |
|
|
2024
Q2 | $555K | Hold |
15,800
| – | – | ﹤0.01% | 987 |
|
|
2024
Q1 | $461K | Hold |
15,800
| – | – | ﹤0.01% | 1015 |
|
|
2023
Q4 | $326K | Hold |
15,800
| – | – | ﹤0.01% | 1115 |
|
|
2023
Q3 | $271K | Hold |
15,800
| – | – | ﹤0.01% | 1144 |
|
|
2023
Q2 | $438K | Hold |
15,800
| – | – | ﹤0.01% | 1046 |
|
|
2023
Q1 | $357K | Hold |
15,800
| – | – | ﹤0.01% | 1086 |
|
|
2022
Q4 | $154K | Hold |
15,800
| – | – | ﹤0.01% | 1260 |
|
|
2022
Q3 | $131K | Hold |
15,800
| – | – | ﹤0.01% | 1281 |
|
|
2022
Q2 | $140K | Hold |
15,800
| – | – | ﹤0.01% | 1245 |
|
|
2022
Q1 | $378K | Buy |
15,800
+1,400
| +10% | +$33.5K | ﹤0.01% | 1109 |
|
|
2021
Q4 | $439K | Buy |
14,400
+400
| +3% | +$12.2K | ﹤0.01% | 1129 |
|
|
2021
Q3 | $246K | Hold |
14,000
| – | – | ﹤0.01% | 1168 |
|
|
2021
Q2 | $616K | Hold |
14,000
| – | – | ﹤0.01% | 1026 |
|
|
2021
Q1 | $354K | Hold |
14,000
| – | – | ﹤0.01% | 1081 |
|
|
2020
Q4 | $300K | Buy |
+14,000
| New | +$300K | ﹤0.01% | 1122 |
|